Literature DB >> 21697367

Nuclear factor-κB contributes to neuron-dependent induction of glutamate transporter-1 expression in astrocytes.

Mausam Ghosh1, Yongjie Yang, Jeffrey D Rothstein, Michael B Robinson.   

Abstract

The glutamate transporter-1 [GLT-1 (excitatory amino acid transporter 2)] subtype of glutamate transporter ensures crisp excitatory signaling and limits excitotoxicity in the CNS. Astrocytic expression of GLT-1 is regulated during development, by neuronal activity, and in neurodegenerative diseases. Although neurons activate astrocytic expression of GLT-1, the mechanisms involved have not been identified. In the present study, astrocytes from transgenic mice that express enhanced green fluorescent protein (eGFP) under the control of a bacterial artificial chromosome (BAC) containing a very large region of DNA surrounding the GLT-1 gene (BAC GLT-1 eGFP mice) were used to assess the role of nuclear factor-κB (NF-κB) in neuron-dependent activation of the GLT-1 promoter. We provide evidence that neurons activate NF-κB signaling in astrocytes. Transduction of astrocytes from the BAC GLT-1 eGFP mice with dominant-negative inhibitors of NF-κB signaling completely blocked neuron-dependent activation of a NF-κB reporter construct and attenuated induction of eGFP. Exogenous expression of p65 and/or p50 NF-κB subunits induced expression of eGFP or GLT-1 and increased GLT-1-mediated transport activity. Using wild-type and mutant GLT-1 promoter reporter constructs, we found that NF-κB sites at -583 or -251 relative to the transcription start site were required for neuron-dependent reporter activation. Electrophoretic mobility shift and supershift assays reveal that p65 and p50 interact with these same sites ex vivo. Finally, chromatin immunoprecipitation showed that p65 and p50 interact with these sites in adult cortex, but not in kidney (a tissue that expresses no detectable GLT-1). Together, these studies strongly suggest that NF-κB contributes to neuron-dependent regulation of astrocytic GLT-1 transcription.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21697367      PMCID: PMC3138498          DOI: 10.1523/JNEUROSCI.0302-11.2011

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  72 in total

Review 1.  NF-kappaB at the crossroads of life and death.

Authors:  Michael Karin; Anning Lin
Journal:  Nat Immunol       Date:  2002-03       Impact factor: 25.606

2.  Neuronal-induced and glutamate-dependent activation of glial glutamate transporter function.

Authors:  Carol L Poitry-Yamate; Laszlo Vutskits; Thomas Rauen
Journal:  J Neurochem       Date:  2002-08       Impact factor: 5.372

3.  Glutamate transporter alterations in Alzheimer disease are possibly associated with abnormal APP expression.

Authors:  S Li; M Mallory; M Alford; S Tanaka; E Masliah
Journal:  J Neuropathol Exp Neurol       Date:  1997-08       Impact factor: 3.685

Review 4.  NF-kappaB in neuronal plasticity and neurodegenerative disorders.

Authors:  M P Mattson; S Camandola
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

5.  Prolonged activation of NF-kappaB following traumatic brain injury in rats.

Authors:  M Nonaka; X H Chen; J E Pierce; M J Leoni; T K McIntosh; J A Wolf; D H Smith
Journal:  J Neurotrauma       Date:  1999-11       Impact factor: 5.269

6.  Glutamate transporter expression in astrocytes of the rat dentate gyrus following lesion of the entorhinal cortex.

Authors:  C Hein; E Horváth; P Kugler
Journal:  Eur J Neurosci       Date:  2001-05       Impact factor: 3.386

Review 7.  Glutamate uptake.

Authors:  N C Danbolt
Journal:  Prog Neurobiol       Date:  2001-09       Impact factor: 11.685

8.  Epidermal growth factor receptor agonists increase expression of glutamate transporter GLT-1 in astrocytes through pathways dependent on phosphatidylinositol 3-kinase and transcription factor NF-kappaB.

Authors:  O Zelenaia; B D Schlag; G E Gochenauer; R Ganel; W Song; J S Beesley; J B Grinspan; J D Rothstein; M B Robinson
Journal:  Mol Pharmacol       Date:  2000-04       Impact factor: 4.436

Review 9.  NF-kappaB regulation in the immune system.

Authors:  Qiutang Li; Inder M Verma
Journal:  Nat Rev Immunol       Date:  2002-10       Impact factor: 53.106

10.  The GLT-1 and GLAST glutamate transporters are expressed on morphologically distinct astrocytes and regulated by neuronal activity in primary hippocampal cocultures.

Authors:  C Perego; C Vanoni; M Bossi; S Massari; H Basudev; R Longhi; G Pietrini
Journal:  J Neurochem       Date:  2000-09       Impact factor: 5.372

View more
  41 in total

1.  Brain endothelial cells induce astrocytic expression of the glutamate transporter GLT-1 by a Notch-dependent mechanism.

Authors:  Meredith L Lee; Zila Martinez-Lozada; Elizabeth N Krizman; Michael B Robinson
Journal:  J Neurochem       Date:  2017-09-05       Impact factor: 5.372

2.  GPR30 regulates glutamate transporter GLT-1 expression in rat primary astrocytes.

Authors:  Eunsook Lee; Marta Sidoryk-Wêgrzynowicz; Ning Wang; Anton Webb; Deok-Soo Son; Kyuwon Lee; Michael Aschner
Journal:  J Biol Chem       Date:  2012-05-29       Impact factor: 5.157

3.  The transcription factor Pax6 contributes to the induction of GLT-1 expression in astrocytes through an interaction with a distal enhancer element.

Authors:  Mausam Ghosh; Meredith Lane; Elizabeth Krizman; Rita Sattler; Jeffrey D Rothstein; Michael B Robinson
Journal:  J Neurochem       Date:  2015-11-24       Impact factor: 5.372

4.  p38 MAPK Participates in the Mediation of GLT-1 Up-regulation During the Induction of Brain Ischemic Tolerance by Cerebral Ischemic Preconditioning.

Authors:  Min Zhang; Jian-Xue Gong; Jia-Lei Wang; Meng-Yang Jiang; Li Li; Yu-Yan Hu; Jie Qi; Ling-Yan Zhang; Hang Zhao; Xin Cui; Xiao-Hui Xian; Wen-Bin Li
Journal:  Mol Neurobiol       Date:  2016-01-05       Impact factor: 5.590

Review 5.  Homocysteine and Gliotoxicity.

Authors:  Angela T S Wyse; Larissa Daniele Bobermin; Tiago Marcon Dos Santos; André Quincozes-Santos
Journal:  Neurotox Res       Date:  2021-03-30       Impact factor: 3.911

Review 6.  Glutamate transporter EAAT2: regulation, function, and potential as a therapeutic target for neurological and psychiatric disease.

Authors:  Kou Takahashi; Joshua B Foster; Chien-Liang Glenn Lin
Journal:  Cell Mol Life Sci       Date:  2015-06-02       Impact factor: 9.261

7.  Estrogen attenuates manganese-induced glutamate transporter impairment in rat primary astrocytes.

Authors:  Eunsook Lee; Marta Sidoryk-Wegrzynowicz; Marcelo Farina; Joao B T Rocha; Michael Aschner
Journal:  Neurotox Res       Date:  2012-08-10       Impact factor: 3.911

Review 8.  Genetic dys-regulation of astrocytic glutamate transporter EAAT2 and its implications in neurological disorders and manganese toxicity.

Authors:  Pratap Karki; Keisha Smith; James Johnson; Michael Aschner; Eunsook Y Lee
Journal:  Neurochem Res       Date:  2014-07-27       Impact factor: 3.996

Review 9.  Role of transcription factor yin yang 1 in manganese-induced reduction of astrocytic glutamate transporters: Putative mechanism for manganese-induced neurotoxicity.

Authors:  Pratap Karki; Keisha Smith; James Johnson; Michael Aschner; Eunsook Lee
Journal:  Neurochem Int       Date:  2014-08-13       Impact factor: 3.921

Review 10.  Astroglial glutamate transporters coordinate excitatory signaling and brain energetics.

Authors:  Michael B Robinson; Joshua G Jackson
Journal:  Neurochem Int       Date:  2016-03-21       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.